Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Age, sex and NK1 receptors in the human brain -- a positron emission tomography study with [¹¹C]GR205171.

Engman J, Åhs F, Furmark T, Linnman C, Pissiota A, Appel L, Frans Ö, Långström B, Fredrikson M.

Eur Neuropsychopharmacol. 2012 Aug;22(8):562-8. doi: 10.1016/j.euroneuro.2011.12.005. Epub 2012 Jan 4.

PMID:
22225860
2.

[3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.

Griffante C, Carletti R, Andreetta F, Corsi M.

Br J Pharmacol. 2006 May;148(1):39-45.

3.

Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11)C]GR205171.

Danfors T, Åhs F, Appel L, Linnman C, Fredrikson M, Furmark T, Kumlien E.

Epilepsy Res. 2011 Nov;97(1-2):183-9. doi: 10.1016/j.eplepsyres.2011.08.006. Epub 2011 Sep 16.

PMID:
21925840
4.

Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.

Nyman MJ, Eskola O, Kajander J, Vahlberg T, Sanabria S, Burns D, Hargreaves R, Solin O, Hietala J.

Int J Neuropsychopharmacol. 2007 Apr;10(2):219-29. Epub 2006 Mar 30.

PMID:
16573846
5.

Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system.

Michelgård A, Appel L, Pissiota A, Frans O, Långström B, Bergström M, Fredrikson M.

Biol Psychiatry. 2007 Apr 15;61(8):1002-6. Epub 2006 Sep 1.

PMID:
16950220
6.

Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.

Frick A, Åhs F, Palmquist ÅM, Pissiota A, Wallenquist U, Fernandez M, Jonasson M, Appel L, Frans Ö, Lubberink M, Furmark T, von Knorring L, Fredrikson M.

Mol Psychiatry. 2016 Oct;21(10):1400-7. doi: 10.1038/mp.2015.180. Epub 2015 Dec 1.

PMID:
26619809
7.

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.

Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM.

J Neurochem. 2004 Apr;89(1):54-63.

8.

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

Frick A, Ahs F, Linnman C, Jonasson M, Appel L, Lubberink M, Långström B, Fredrikson M, Furmark T.

Transl Psychiatry. 2015 Jul 7;5:e597. doi: 10.1038/tp.2015.92.

9.

Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.

Syvänen S, Eriksson J, Genchel T, Lindhe O, Antoni G, Långström B.

BMC Med Imaging. 2007 Jul 30;7:6.

10.

Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ.

Okumura M, Arakawa R, Ito H, Seki C, Takahashi H, Takano H, Haneda E, Nakao R, Suzuki H, Suzuki K, Okubo Y, Suhara T.

J Nucl Med. 2008 Nov;49(11):1749-55. doi: 10.2967/jnumed.108.054353. Epub 2008 Oct 16.

11.

Netupitant PET imaging and ADME studies in humans.

Spinelli T, Calcagnile S, Giuliano C, Rossi G, Lanzarotti C, Mair S, Stevens L, Nisbet I.

J Clin Pharmacol. 2014 Jan;54(1):97-108. doi: 10.1002/jcph.198. Epub 2013 Nov 8.

12.

Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging.

Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, Szczepanik J, Schapiro MB, Grady CL, Horwitz B, Rapoport SI.

Arch Gen Psychiatry. 1996 Jul;53(7):585-94.

PMID:
8660125
13.

Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist.

Hutson PH, Patel S, Jay MT, Barton CL.

Eur J Pharmacol. 2004 Jan 19;484(1):57-64.

PMID:
14729382
14.

Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the rat.

Kalinichev M, Bradford A, Bison S, Lucas A, Sartori I, Garbati N, Andreetta F, Bate S, Austin NE, Jones DN, Read KD, Alvaro G, Large CH.

Epilepsia. 2010 Aug;51(8):1543-51. doi: 10.1111/j.1528-1167.2009.02482.x. Epub 2010 Jan 7.

15.

Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171--PET studies in rhesus monkey.

Bergström M, Fasth KJ, Kilpatrick G, Ward P, Cable KM, Wipperman MD, Sutherland DR, Långström B.

Neuropharmacology. 2000 Feb 14;39(4):664-70.

PMID:
10728887
16.

Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429.

Singewald N, Chicchi GG, Thurner CC, Tsao KL, Spetea M, Schmidhammer H, Sreepathi HK, Ferraguti F, Singewald GM, Ebner K.

J Neurochem. 2008 Sep;106(6):2476-88. doi: 10.1111/j.1471-4159.2008.05596.x. Epub 2008 Jul 30.

17.

Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.

Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M, Carletti R.

Eur J Neurosci. 2003 May;17(9):1736-46.

PMID:
12752772
18.

First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in man.

Wolfensberger SP, van Berckel BN, Airaksinen AJ, Maruyama K, Lubberink M, Boellaard R, Carey WD, Reddingius W, Veltman DJ, Windhorst AD, Leysen JE, Lammertsma AA.

Mol Imaging Biol. 2009 Jul-Aug;11(4):241-5. doi: 10.1007/s11307-009-0204-5. Epub 2009 Mar 31.

19.
20.

PET-scan shows peripherally increased neurokinin 1 receptor availability in chronic tennis elbow: visualizing neurogenic inflammation?

Peterson M, Svärdsudd K, Appel L, Engler H, Aarnio M, Gordh T, Långström B, Sörensen J.

PLoS One. 2013 Oct 14;8(10):e75859. doi: 10.1371/journal.pone.0075859. eCollection 2013.

Supplemental Content

Support Center